This CME-accredited activity, Updates in Cellular Therapy, is designed to improve the knowledge and competence of learners to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients with hematologic malignancies and to describe potential future applications of cellular therapy in solid tumors. This activity is designed to provide physicians, physician assistants, nurse practitioners, pharmacists, nurses, and other healthcare professionals with the latest updates in the field. It will highlight a multidisciplinary approach and the integration of new advances in patient-centered care of cellular therapy.
Course Accreditations
1 AMA PRA Category 1 Credit™ The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 1.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission. 1 Nursing Contact Hours Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 1.00 Contact Hours. 1 ABIM MOC II Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Course Summary
| Events Starts | Events Ends |
|---|---|
| 3/12/2025 | 3/12/2025 |
- Hematologists/Medical Oncologists
- Oncology fellows
- Oncology nurses
- NPs/PAs
- Oncology pharmacists
Target Audience
- Review indications and outcomes of approved cellular therapies in hematologic malignancies
- Identify emerging cellular therapies in hematologic malignancies and solid tumors
- Identify and manage complications after cellular therapy
- State the financial, physical, and other barriers, review strategies to navigate these factors to optimize the management of patients with cellular therapies
Learning Objectives
Upon successful completion of this educational activity, participants will be able to: